These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37017261)

  • 1. Psyllium seed husk regulates the gut microbiota and improves mucosal barrier injury in the colon to attenuate renal injury in 5/6 nephrectomy rats.
    Hu D; Liu W; Yu W; Huang L; Ji C; Liu X; Lu Z
    Ren Fail; 2023 Dec; 45(1):2197076. PubMed ID: 37017261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the mechanism of hirudin multi target delaying renal function decline in chronic kidney disease based on the "gut-kidney axis" theory.
    Long C; Zhang C; Xie Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7951-7962. PubMed ID: 38758227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by
    Tungsanga S; Panpetch W; Bhunyakarnjanarat T; Udompornpitak K; Katavetin P; Chancharoenthana W; Chatthanathon P; Somboonna N; Tungsanga K; Tumwasorn S; Leelahavanichkul A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in a 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules.
    Tungsanga S; Katavetin P; Panpetch W; Udompornpitak K; Saisorn W; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Tumwasorn S; Leelahavanichkul A
    Nephrol Dial Transplant; 2022 Jul; 37(8):1429-1442. PubMed ID: 35138387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.
    Zhao J; Zhao C; Xun T; Wang X; Wei S; Ye C; Zhang M; Guo D; Yang X
    Drug Des Devel Ther; 2024; 18():13-28. PubMed ID: 38205394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease.
    Yang J; Lim SY; Ko YS; Lee HY; Oh SW; Kim MG; Cho WY; Jo SK
    Nephrol Dial Transplant; 2019 Mar; 34(3):419-428. PubMed ID: 29939312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dietary fiber on chronic kidney disease： Base on the gut-kidney axis theory.
    Xie X; Dai S; Dai Y; Ning J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):193-197. PubMed ID: 32386047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease after 5/6 nephrectomy disturbs the intestinal microbiota and alters intestinal motility.
    Nishiyama K; Aono K; Fujimoto Y; Kuwamura M; Okada T; Tokumoto H; Izawa T; Okano R; Nakajima H; Takeuchi T; Azuma YT
    J Cell Physiol; 2019 May; 234(5):6667-6678. PubMed ID: 30317589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis.
    Ji C; Lu F; Wu Y; Lu Z; Mo Y; Han L; Lin Q; Liu X; Zou C
    Biomed Res Int; 2022; 2022():1896781. PubMed ID: 35097110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification.
    Ji C; Deng Y; Yang A; Lu Z; Chen Y; Liu X; Han L; Zou C
    Front Pharmacol; 2020; 11():1092. PubMed ID: 32848732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.
    Melekoglu E; Cetinkaya MA; Kepekci-Tekkeli SE; Kul O; Samur G
    PLoS One; 2021; 16(10):e0258145. PubMed ID: 34614017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oat Dietary Fiber Delays the Progression of Chronic Kidney Disease in Mice by Modulating the Gut Microbiota and Reducing Uremic Toxin Levels.
    Xia J; Zhang Y; Zhang S; Lu C; Huan H; Guan X
    J Agric Food Chem; 2024 Jun; ():. PubMed ID: 38836841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uremic toxins and gut micro biome].
    Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
    Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
    Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats with Chronic Kidney Disease.
    Lau WL; Vaziri ND; Nunes ACF; Comeau AM; Langille MGI; England W; Khazaeli M; Suematsu Y; Phan J; Whiteson K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):452-460. PubMed ID: 30287477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.